Age-dependent penetrance of different germline mutations in the BRCA1 gene

Journal of Clinical Pathology

Volumn 62, Issue 4, 2009, Pages 350-356

  Al Mulla, F ^a   Bland, J M ^b   Serratt, D ^c   Miller, J ^c   Chu, C ^c   Taylor, G T ^c  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNIVERSITY OF YORK   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; DISEASE ASSOCIATION; EXON; FAMILY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; ONSET AGE; OVARY CANCER; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; OVARIAN NEOPLASMS; PEDIGREE; PENETRANCE; SURVIVAL ANALYSIS;

EID: 65849507260     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.062646     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Narod SA. Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer 2002;2:113-123 (Pubitemid 37328798)
3. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71. (Pubitemid 24345325)
4. Tavtigian SV, Simard J, Rommens J, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996;12:333-337 (Pubitemid 26080098)
5. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-2090 (Pubitemid 24325690)
6. Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRC/4/-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692-695
7. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-689
8. Begg CB. On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 2002;94:1221-1226 (Pubitemid 34721635)
9. Gayther Sa, Warren W, Mazoyer S, et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 1995;11:428-433
10. Couch FJ, DeShano ML, Blackwood MA, etal. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997;336:1409-1415 (Pubitemid 27208599)
11. Frank TS, Manley SA, Olopade OI, et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 1998;16:2417-2425 (Pubitemid 28309036)
12. Serova O, Montagna M, Torchard D, etal. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 1996;58:42-51.
13. Gayther SA, Mangion J, Russell P, et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 1997;15:103-105 (Pubitemid 27014960)
14. Neuhausen SL, Godwin AK, Gershoni-Baruch R, et al. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet 1998;62:1381-1388
15. Thompson D, Easton D. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 2001;68:410-419 (Pubitemid 32147810)
16. Al-Mulla F. http://www.al-mulla.org/breastcancer.html (accessed 15 December 2008).
17. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989;84:1074-1078
18. National Human Genome Research Institute. Breast Cancer Information Core database. http://research.nhgri.nih.gov/bic/ (accessed 15 December 2008).
19. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-1130 (Pubitemid 36530000)
20. Chatterjee N, Wacholder S. A marginal likelihood approach for estimating penetrance from kin-cohort designs. Biometrics 2001;57:245-252 (Pubitemid 32200163)
21. Kraft P, Thomas DC. Bias and efficiency in family-based gene-characterization studies: conditional, prospective, retrospective, and joint likelihoods. Am J Hum Genet 2000;66:1119-1131 (Pubitemid 30470509)
22. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet 1997;60:1013-1020 (Pubitemid 27194085)
23. Gayther SA, Harrington P, Russell P, et al. Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Hum Genet 1997;60:1239-1242 (Pubitemid 27194110)
24. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996;13:117-119 (Pubitemid 126528241)
25. The BRCA1 Exon 13 Duplication Screening Group. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. Am J Hum Genet 2000;67:207-212
26. Xu CF, Chambers JA, Nicolai H, et al. Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer 1997; 18:102-110
27. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-1689 (Pubitemid 120031871)
28. Phelan CM, Lancaster JM, Tonin P, etal. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet 1996;13:120-122 (Pubitemid 126528242)
29. Thompson D, Easton DF. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002;94:1358-1365 (Pubitemid 35154140)
30. Unger MA, Nathanson KL, Calzone K, et al. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 2000;67:841-850
31. Yap KP, Ang P, Lim IH, et al. Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing. Clin Genet 2006;70:80-82 (Pubitemid 44192742)
32. Steinitz R, Parkin DM, Young JL, et al. Cancer incidence in Jewish migrants to Israel, 1961-1981. IARC Sci Publ 1989:1-311.
33. Antoniou AC, Pharoah PD, Narod S, etal. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 2005;42:602-603 (Pubitemid 40993838)
34. Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, et al. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum Mol Genet 2002;11:2805-2814 (Pubitemid 35331813)
35. Buisson M, Anczukow 0, Zetoune AB, et al. The 185delAG mutation (c.68-69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon. Hum Mutat 2006;27:1024-1029 (Pubitemid 44454055)
36. Rashid MU, Zaidi A, Torres D, et al. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer 2006;119:2832-2839